Double-blind controlled study
En Español (Spanish Version)

The best and most reliable form of research is the double-blind placebo-controlled study. The purpose of this kind of study is to eliminate the power of suggestion. It is true, although hard to believe, that placebo (fake) treatments can produce dramatic and long-lasting results in a majority of the people who are given them. The double-blind controlled study keeps both doctors and participants in the dark as to who is receiving which treatment. This last part is important because it prevents the researchers from unintentionally tipping off the study participants, or unconsciously biasing their evaluation of the results.

A good double-blind study should enroll at least 100 people, preferably as many as 300. Dramatically effective treatments can prove themselves in somewhat smaller trials; however, research involving 30 or fewer people generally doesn't prove anything at all.

A double-blindcomparative study is similar to a double-blind placebo-controlled study , except that instead of placebo, one group receives a standard drug. Therefore, such studies compare a new drug to another that is already known to work.

Such studies are especially useful in determining whether a new treatment offers any advantages over an old one. For statistical reasons, they are not quite as good at proving whether a treatment is effective.




Health Information Library content is provided by EBSCO Publishing, fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

 

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

 

To send comments or feedback to EBSCO's Editorial Team regarding the content please e-mail healthlibrarysupport@ebscohost.com.